Controlling bacterial disease without antibiotics

We have developed bacteriophages for application in crop science, animal health, food safety as well as human applications.

Reduces the need for antibiotics and chemicals (like copper) that causes disease, create AMR, and reduce productivity.

  • Infection prevention
  • Antimicrobial stewardship
  • Antimicrobial compound/strategy
  • Microbial diagnostics
  • Removal antibiotics/bacteria

  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Marketed product
  • Research
  • Development
  • Validation
  • Market entry

  • Company
  • Academia
  • Institute
  • NGO
  • Government

  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND

Infectious disease area:
  • UTI
  • STI
  • RTI
  • GII
  • SSTI
  • SSI
  • BSI
  • CNSI
  • IAI

Geographic origin:
  • North America
  • South America
  • Eurasia
  • Africa
  • Oceania

Phagelux Agrihealth, and its subsidiary Omnilytics, are changing the way the world addresses bacterial disease in agriculture reducing the need for the use of antibiotics as well as reducing the reservoirs of anti-microbial resistance.

We have a sister company developing phage applications in wound care as well as in human drug applications.

We are researching additional applications in human health as well as diagnostic tools to enable higher precision use of bacteriophages in the field.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed